BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261106T080000
DTEND;TZID=America/Halifax:20261106T090000
DTSTAMP:20261016T203637Z
CREATED:20261016T203637Z
LAST-MODIFIED:20261016T203637Z
UID:10001107-1793952000-1793955600@oncodaily.com
SUMMARY:Seismic Shift: Innovations in MRD Testing and Pathology
DESCRIPTION:Seismic Shift: Innovations in MRD Testing and Pathology will take place on November 6\, 2026\, as a live virtual session hosted by OncoDaily in partnership with Natera. \nThe webinar will explore the rapidly evolving role of Molecular Residual Disease (MRD) testing in cancer care\, with a focus on technological advances\, personalized ctDNA approaches\, biomarker tracking\, and the integration of modern testing into pathology workflows. \nThe session will examine how emerging MRD technologies are changing cancer monitoring and moving patient management toward more precise\, individualized approaches. Participants will learn about advances in multimodal testing\, high-sensitivity liquid biopsy methodologies\, and digital platforms\, while also exploring how modern assays can improve analytical sensitivity\, specificity\, and turnaround times. \nThe webinar will also address the practical side of implementing MRD testing\, including specimen logistics\, tissue stewardship\, workflow optimization\, and standardized reporting. Dr. Joe Lennerz will discuss the technological and clinical strategies driving this shift\, with the session designed to help oncology and diagnostic professionals better understand how these developments can generate consistent and actionable insights for patient care. \n 
URL:https://oncodaily.com/event/seismic-shift-609977
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_2982-1-1-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261106T080000
DTEND;TZID=America/Halifax:20261106T090000
DTSTAMP:20261005T140305Z
CREATED:20261005T140305Z
LAST-MODIFIED:20261005T140305Z
UID:10001095-1793952000-1793955600@oncodaily.com
SUMMARY:OncoDaily – Seismic Shift: Innovations in MRD Testing and Pathology
DESCRIPTION:The OncoDaily – Seismic Shift: Innovations in MRD Testing and Pathology webinar will take place on November 6\, 2026\, online via X (OncoDaily). \nOrganized by OncoDaily in partnership with Natera\, the session will explore recent advances in Molecular Residual Disease (MRD) testing\, including multimodal testing\, personalized circulating tumor DNA (ctDNA) technology\, dynamic biomarker tracking\, and evolving pathology workflows. \nThe webinar will examine how modern MRD methodologies are improving analytical sensitivity\, specificity\, turnaround times\, and clinical monitoring across solid and hematologic malignancies. The session will also address practical approaches to optimizing tissue stewardship\, specimen logistics\, and standardized reporting to support reliable and actionable results.
URL:https://oncodaily.com/event/mrd-testing-and-pathology-601378
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_2982-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261105
DTEND;VALUE=DATE:20261106
DTSTAMP:20261005T135524Z
CREATED:20261005T135524Z
LAST-MODIFIED:20261005T135524Z
UID:10001094-1793836800-1793923199@oncodaily.com
SUMMARY:LungÕ 2026 – Virtual Global Congress on Lung Oncology
DESCRIPTION:The LungÕ 2026 – Virtual Global Congress on Lung Oncology will take place on November 5\, 2026\, online. \nAs part of OncoDaily’s O Series\, the congress will bring together international experts in lung oncology to discuss advances across the full spectrum of lung cancer care\, from early-stage disease through locally advanced and metastatic settings. \nThe congress will focus on early detection\, precision diagnostics\, biomarker-driven treatment selection\, multidisciplinary care\, targeted therapies\, immunotherapy\, treatment sequencing\, resistance mechanisms\, and individualized patient-centered care across both non-small cell and small cell lung cancer. \nThe programme will also examine how recent developments can be translated into everyday clinical practice\, with an emphasis on improving treatment selection\, refining therapeutic sequencing\, strengthening multidisciplinary care\, and addressing disparities in access and outcomes.
URL:https://oncodaily.com/event/lungo-2026-601365
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_0900-1-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261025T140000
DTEND;TZID=America/Halifax:20261025T180000
DTSTAMP:20261016T203111Z
CREATED:20261016T203111Z
LAST-MODIFIED:20261016T203111Z
UID:10001106-1792936800-1792951200@oncodaily.com
SUMMARY:OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition
DESCRIPTION:OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition will take place on October 25\, 2026\, at Novotel Madrid Feria and Airport in Madrid\, Spain. \nChaired by Prof. Andrea Necchi\, this one-day\, in-person event will bring together international experts to discuss the scientific developments\, clinical questions\, and practical treatment decisions shaping bladder cancer care. \nThe programme will combine expert presentations\, interactive faculty discussions\, live polling\, and audience participation. The first part\, “Expert Perspectives: What Would You Do?”\, will address treatment approaches in localised bladder cancer\, advanced urothelial carcinoma\, treatment selection and sequencing\, toxicity\, patient preferences\, and multidisciplinary decision-making. \nThe second part\, “One Clinical Scenario\, Different Countries\,” will bring together international faculty to explore how guidelines\, treatment access\, available resources\, and local healthcare settings influence bladder cancer management across different countries. \n 
URL:https://oncodaily.com/event/bladder-cancer-edition-609963
LOCATION:Novotel Madrid Feria and Airport\, Calle de Ámsterdam\, 3\, Campo de las Naciones\, Madrid\, Community of Madrid\, 28042\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4462-1-2.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261024T181500
DTEND;TZID=America/Halifax:20261024T201500
DTSTAMP:20261005T133159Z
CREATED:20261005T133159Z
LAST-MODIFIED:20261005T133159Z
UID:10001092-1792865700-1792872900@oncodaily.com
SUMMARY:OncoDaily – Big Questions During ESMO 2026
DESCRIPTION:OncoDaily – Big Questions During ESMO 2026 will take place on October 24\, 2026\, from 6:15 PM to 8:15 PM in Madrid\, Spain\, during the ESMO 2026 Congress. \nThe session\, chaired by Prof. Jean-Yves Blay\, will bring together clinicians\, clinical trialists\, researchers\, regulators\, policymakers\, patient advocates\, and other oncology leaders for an open discussion of the decisions that shape cancer research\, drug development\, regulation\, and patient access. \nRather than a traditional lecture programme\, the event will centre on a moderated two-hour panel discussion\, with dedicated time for audience questions and participation. The discussion will examine how different stakeholders approach critical decisions across the oncology ecosystem and where perspectives align or diverge. \nKey topics will include the fragility of clinical evidence\, what happens when important trials end prematurely\, how much uncertainty should be accepted in regulatory approvals\, the divide between regulatory and clinical interpretation of evidence\, and the persistent gap between a treatment being approved and actually becoming available to patients. \nThe panel will also explore questions around research funding\, trial continuation and closure\, commercially unattractive research questions\, evidence thresholds for changing clinical practice\, health economics\, reimbursement\, and equitable access to cancer treatments.
URL:https://oncodaily.com/event/big-questions-during-esmo-2026-601323
LOCATION:Madrid\, Madrid\, Community of Madrid\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4005-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261024T133000
DTEND;TZID=America/Halifax:20261024T163000
DTSTAMP:20261016T201951Z
CREATED:20261016T201951Z
LAST-MODIFIED:20261016T201951Z
UID:10001105-1792848600-1792859400@oncodaily.com
SUMMARY:OncoDaily – Who Owns the Message Brunch during ESMO 2026
DESCRIPTION:Who Owns the Message Brunch during ESMO 2026\, organized by OncoDaily\, will take place on October 24\, 2026\, at Club de Golf Olivar de la Hinojosa in Madrid\, Spain. \nThe invitation-only brunch will bring together a select group of senior communications\, corporate affairs\, public affairs\, and marketing leaders from the pharmaceutical and healthcare industry for an intimate discussion about the changing landscape of healthcare communication. \nAs scientific information moves faster\, audiences become increasingly fragmented\, patients gain a stronger voice\, social media can reshape narratives within hours\, and artificial intelligence changes how information is created and consumed\, healthcare communication is becoming increasingly complex. The brunch will provide a space for leaders to step outside formal presentations and openly discuss the challenges they face while balancing scientific accuracy\, corporate reputation\, regulatory requirements\, stakeholder expectations\, and trust. \nRather than a traditional conference or networking event\, Who Owns the Message? is designed as a candid conversation about who shapes healthcare narratives today\, how different stakeholders influence communication\, and how the industry can build more effective\, trusted\, and impactful approaches to communicating about healthcare and science. \n 
URL:https://oncodaily.com/event/esmo-2026-609951
LOCATION:Club de Golf Olivar de la Hinojosa\, Casa Ramon\, Av. del Partenón\, 10\, Barajas\, Madrid\, Community of Madrid\, 28042\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4280-1-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261023T130000
DTEND;TZID=America/Halifax:20261023T160000
DTSTAMP:20261005T132228Z
CREATED:20261005T132228Z
LAST-MODIFIED:20261005T132228Z
UID:10001090-1792760400-1792771200@oncodaily.com
SUMMARY:OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
DESCRIPTION:OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition will take place on October 23\, 2026\, from 1:00 PM to 4:00 PM at the Novotel Madrid Feria and Airport in Madrid\, Spain. \nThe special live session will be held during the ESMO 2026 Congress and will continue the sarcoma-focused discussion following the successful Sarcoma Grand Rounds held during ASCO 2026. \nThe session will bring together leading experts in sarcoma to discuss developments shaping the field and explore how emerging evidence may influence treatment strategies and future directions in sarcoma care. The program will be co-chaired by Prof. Robin Jones and Prof. Javier Martín-Broto. \nJust 2 minutes’ walk from IFEMA Madrid\, the event is designed as an opportunity for experts to continue the conversation around advances in sarcoma during ESMO 2026.
URL:https://oncodaily.com/event/oncodaily-grand-rounds-601296
LOCATION:Novotel Madrid Feria and Airport\, Calle de Ámsterdam\, 3\, Campo de las Naciones\, Madrid\, Community of Madrid\, 28042\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/10-5-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261023T080000
DTEND;TZID=America/Halifax:20261023T170000
DTSTAMP:20261016T195652Z
CREATED:20261016T195652Z
LAST-MODIFIED:20261016T195652Z
UID:10001091-1792742400-1792774800@oncodaily.com
SUMMARY:OncoDaily Party 2026: Madrid Midnight
DESCRIPTION:The OncoDaily Party 2026: Madrid Midnight will bring together the global oncology community for an evening of connection\, music\, and celebration during ESMO 2026. Taking place at Gabana Madrid on October 23\, the event continues the OncoDaily Party tradition of bringing oncology professionals together beyond the congress halls\, creating a relaxed space to reconnect with colleagues\, meet new members of the community\, and celebrate the people moving oncology forward. \nFollowing previous OncoDaily parties in Chicago\, Barcelona\, and Berlin\, the Madrid edition will offer an opportunity to step away from the busy congress schedule and enjoy an evening surrounded by friends\, colleagues\, and members of the international oncology community. Guests can expect DJ sets\, conversations\, new connections\, and a lively atmosphere extending well into the night. \nAdmission is by invitation only.
URL:https://oncodaily.com/event/oncodaily-party-2026-601316
LOCATION:Gabana Madrid\, Calle de María de Molina\, 39\, Madrid\, Community of Madrid\, 28006\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4574-2-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261016T080000
DTEND;TZID=America/Halifax:20261016T170000
DTSTAMP:20261016T205616Z
CREATED:20261016T205616Z
LAST-MODIFIED:20261016T205616Z
UID:10001108-1792137600-1792170000@oncodaily.com
SUMMARY:Precision Medicine in Colorectal Cancer: Harnessing the Power of MRD Surveillance and Emerging Guidelines
DESCRIPTION:Precision Medicine in Colorectal Cancer: Harnessing the Power of MRD Surveillance and Emerging Guidelines will take place on November 13\, 2026\, as a live virtual webinar hosted by OncoDaily in partnership with Natera. \nThe session will focus on the growing role of circulating tumor DNA (ctDNA) and molecular residual disease (MRD) testing in the evolving management of colorectal cancer. \nLed by Dr. Rob Lentz\, the webinar will explore how longitudinal ctDNA surveillance can inform post-operative monitoring and adjuvant treatment decisions. Participants will review emerging clinical evidence\, updated consensus guidelines\, and real-world data on serial ctDNA monitoring\, including its potential to identify recurrence earlier than standard imaging. \nThe discussion will also examine practical decision-making frameworks around treatment escalation and de-escalation in the adjuvant setting\, as well as emerging neoadjuvant immunotherapy combinations. The session is designed to provide clinicians with an understanding of how personalized molecular monitoring is influencing the future of colorectal cancer care.
URL:https://oncodaily.com/event/colorectal-cancer-609983
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_2938-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260903
DTEND;VALUE=DATE:20260905
DTSTAMP:20260728T135757Z
CREATED:20260728T135757Z
LAST-MODIFIED:20260728T135757Z
UID:10000838-1788393600-1788566399@oncodaily.com
SUMMARY:LeukO 2026: Global Virtual Congress on Leukemias
DESCRIPTION:The LeukO 2026 Global Virtual Congress on Leukemias\, organized by OncoDaily\, will take place online on 3–4 September 2026\, bringing together international experts for more than 40 scientific sessions on leukemia diagnosis\, treatment\, research\, and multidisciplinary care. \nLed scientifically by Marina Konopleva and Rami Komrokji\, the programme will cover molecular genetics\, risk stratification\, measurable residual disease\, artificial intelligence in diagnostics\, and current and emerging approaches across AML\, ALL\, CML\, CLL\, and rare leukemias. \nAdditional sessions will address targeted therapies\, CAR-T and bispecific antibodies\, transplantation\, relapse and treatment resistance\, supportive care\, fertility\, survivorship\, clinical-trial innovation\, and access to advanced treatment in resource-limited settings. The virtual congress is designed for clinicians\, researchers\, laboratory specialists\, nurses\, pharmacists\, trainees\, policymakers\, and patient advocates involved in leukemia care.
URL:https://oncodaily.com/event/553448
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_7439.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
END:VCALENDAR